INVA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Innoviva Inc (INVA) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company shows strong financial growth, positive analyst sentiment, and potential for significant upside in the future due to its diversified revenue streams and strategic investments.
The MACD histogram is negative but contracting, RSI is neutral at 67.847, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level of 22.212, with resistance at 22.71 and support at 21.713.
Analysts have raised price targets to $32 and $35, citing strong revenue growth, royalties, and strategic investments.
Financials show significant YoY growth in revenue (24.84%), net income (707.36%), and EPS (822.73%).
The company is positioned to capture over $1.2B in royalties through 2030 and has multiple growth catalysts.
Gross margin dropped by -22.42% YoY, which could indicate rising costs or pricing pressures.
No recent news or significant insider/hedge fund trading activity to provide additional momentum.
In Q4 2025, Innoviva reported revenue of $114.6M (up 24.84% YoY), net income of $164.15M (up 707.36% YoY), and EPS of 2.03 (up 822.73% YoY). However, gross margin declined to 66.02%, down -22.42% YoY.
Analysts are optimistic, with Cantor Fitzgerald raising the price target to $32 and BTIG initiating coverage with a Buy rating and a $35 price target. Both highlight the company's strong revenue growth, royalties, and strategic investments as key drivers for future upside.
